Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Manidipine 6300. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C known ✓ | Q13936 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.71 |
| ▸ | MAPT | P10636 | 7/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.69 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.69 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.69 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.69 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.69 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.69 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.69 |
| ▸ | TP53 | P04637 | 2/20 | 0.69 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Manidipine 6300 SCHEMBL247919 | 1.00 | ADRA1A (0.71) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL137616 | 1.00 | ADRA1A (0.71) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL1491200 | 1.00 | ADRA1A (0.71) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL137617 | 1.00 | ADRA1A (0.71) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL1491187 | 0.99 | ADRA1A (0.70) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL1491189 | 0.99 | ADRA1A (0.70) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL28927600 | 0.99 | ADRA1A (0.70) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL247471 | 0.99 | MAPT (0.70) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL29801590 | 0.99 | MAPT (0.70) | ADRA1AMAPTTDP1MEN1KMT2A | |
| Manidipine 6300 SCHEMBL49368 | 0.99 | MAPT (0.70) | ADRA1AMAPTTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0628313-B1 | Combination of an angiotensin-II antagonising benzimidazole with manidipine for the treatment of hypertension | TAKEDA PHARMACEUTICAL (JP) | 2005-11-30 | — | — | EP | disclosed |